Baxter International Inc. (LON:0QK8)
London · Delayed Price · Currency is GBP · Price in USD 21.97
+0.33 (1.51%)
At close: Sep 26, 2025
Baxter International Market Cap
Baxter International has a market cap or net worth of 8.56 billion as of September 30, 2025. Its market cap has decreased by -44.33% in one year.
Market Cap
8.56B
Enterprise Value
14.52B
Revenue
7.95B
Ranking
n/a
PE Ratio
n/a
Stock Price
21.97
Market Cap Chart
Since January 2, 1968, Baxter International's market cap has increased from 611.84M to 8.56B, an increase of 1,298.29%. That is a compound annual growth rate of 4.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2025 | 8.56B | -28.06% |
| Dec 31, 2024 | 11.89B | -22.76% |
| Dec 29, 2023 | 15.40B | -27.80% |
| Dec 30, 2022 | 21.33B | -32.81% |
| Dec 31, 2021 | 31.74B | 5.75% |
| Dec 31, 2020 | 30.02B | -6.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 170.58B |
| GSK plc | 59.81B |
| Haleon | 29.41B |
| Smith & Nephew | 11.42B |
| ConvaTec Group | 4.54B |
| Hikma Pharmaceuticals | 3.64B |
| HUTCHMED (China) | 1.98B |
| Genus | 1.52B |